Milano, MI Italia (PressExposure) June 18, 2012 -- myHealthbox, the largest European drugs information service, started with the clear objective of promoting the safe and informed use of medicinal products by making the best possible information available to everyone on any device.
myHealthbox is pleased to announce full coverage for medicines and healthcare products sold in the Republic of Ireland.
Medicines' details and information leaflets are available for all products sold in this country on any of the supported devices.
The iPhone client can be downloaded at the following link: http://itunes.apple.com/us/app/myhealthbox/id435937042
the Android OS client is available at: https://market.android.com/search?q=myhealthbox
the WindowsPhone is available at: [http://windowsphone.com/s?appid=49c3ad24-d2f9-47b6-811a-d76f234daa60]
A report published by Altroconsumo in 2007 about Patient Information Leaflets (PILs) available for the most popular medicinal products sold in Italy found them lacking in information and safe use instructions. None of the leaflets showed an emergency contact number and textual information lacked clarity and was at times ambiguous.
In regards to simplicity of use and comprehension, Altroconsumo declares that the effort put into the leaflets available for Over The Counter drugs in Italy from 1997 showed some improvements even if the review process is still far from complete and is still going on today.
In the Bollettino del Farmaco number 51 from AIFA it is stated that:"the new PILs must take a form that makes them easier to comprehend, supported by the use of familiar terminology which improves understanding of drugs-specific language regardless of education level. This can be achieved through the use of short, effective messages based on icons. "
Healthcare industries, which carry the main responsibility in relation to the safe use of their products, must guarantee that any suspected adverse reaction event related to their products is promptly relayed to the relevant authorities and, in order to fulfil this obligation, require advanced information collection and patient monitoring tools. myHealthbox is a solution for the design and distribution of an enhanced, digital version (eLeaflet) of the paper-based patient information leaflets commonly found in healthcare products packaging; myHealthbox provides an answer to both the consumers' and the healthcare industry's needs.
Compared to the traditional paper-based leaflet the eLeafletÂ® is fully multimedia enabled and allows the distribution of images, video and text without size or formats limitations.
The basic idea behind this is the need of establishing a direct channel between the producer and the consumer thus allowing the provisioning of a number of value added services such as: real time information and leaflets updates, direct marketing and DTCA (Direct To Consumer Advertising) through the use of advanced mobile devices (smartphones, tablets and eReaders).
The end result is not only the digitalization of a paper leaflet but a totally new concept with added search and navigation functionalities, enriched with full multimedia capabilities and distributed purely through digital channels.
The actual content is product specific and totally customized but some parts are present in almost all products: a textual description of how best to use a medicine, information about the manufacturer and the helpline numbers, the adverse reaction form and the links to follow in order to obtain further information.
The advantages of such a solution are obvious: on the one side the consumer receives in a simple and effective way precise information about the medicines he/she is interested in and can navigate this information through a standardized paradigm; on the other side the producer can establish a direct link with its customers with clear advantages in terms of product safety, marketing and brand loyalty.
myHealthbox adopts a simple and straightforward process to communicate adverse reactions. Collected information is sent directly to the pharmaceutical company which will then follow up the case according to the specific country guidelines.
As with all medicinal content eLeaflet content follows the same approval route as other information related to medicines including the information included in the paper leaflets, the specific approval process is country specific.
myHealthbox information is updated in real-time and available through a number of devices and clients. The eLeaflet and related services are distributed via a generic web client or a dedicated client available for the most common mobile platforms.